Impact of CD34+ Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
2020 ◽
Vol 26
(3)
◽
pp. S287-S288
2017 ◽
Vol 23
(3)
◽
pp. S38
2021 ◽
Vol 27
(3)
◽
pp. S136-S137
2018 ◽
Vol 53
(5)
◽
pp. 521-534
◽
2020 ◽
Vol 26
(10)
◽
pp. 1955-1962
2019 ◽
Vol 55
(2)
◽
pp. 376-383
◽
2014 ◽
Vol 20
(9)
◽
pp. 1262-1273
◽